RhumbLine Advisers’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $726K | Sell |
|
|||||
|
2025
Q2 | $619K | Buy |
|
|||||
|
2025
Q1 | $356K | Buy |
|
|||||
|
2024
Q4 | $454K | Buy |
|
|||||
|
2024
Q3 | $920K | Sell |
|
|||||
|
2024
Q2 | $568K | Buy |
|
|||||
|
2024
Q1 | $500K | Sell |
|
|||||
|
2023
Q4 | $443K | Sell |
|
|||||
|
2023
Q3 | $586K | Buy |
|
|||||
|
2023
Q2 | $719K | Buy |
|
|||||
|
2023
Q1 | $234K | Buy |
|
|||||
|
2022
Q4 | $345K | Buy |
|
|||||
|
2022
Q3 | $321K | Buy |
|
|||||
|
2022
Q2 | $225K | Buy |
|
|||||
|
2022
Q1 | $272K | Buy |
|
|||||
|
2021
Q4 | $338K | Sell |
|
|||||
|
2021
Q3 | $560K | Buy |
|
|||||
|
2021
Q2 | $556K | Buy |
|
|||||
|
2021
Q1 | $428K | Sell |
|
|||||
|
2020
Q4 | $405K | Buy |
|
|||||
|
2020
Q3 | $400K | Sell |
|
|||||
|
2020
Q2 | $421K | Buy |
|
|||||
|
2020
Q1 | $295K | Buy |
|
|||||
|
2019
Q4 | $218K | Buy |
|